Overview

We are committed to creating positive, lasting change for patients, communities, and the planet. Through a powerful ESG (Environmental, Social, and Governance) framework, we aim to make meaningful impact, delivering value to all stakeholders, while advancing both human and planetary health.

At Biocon Biologics, responsibility is woven into every aspect of our mission to make healthcare accessible. We recognize the profound connection between human and planetary health, driving us to create sustainable solutions that benefit both. Our strategic focus on biosimilars expands access to life-saving treatments for millions of patients worldwide, while our commitment to environmental stewardship ensures we reduce greenhouse gas emissions, transition to renewable energy, and promote responsible sourcing and recycling. We also prioritize fostering an inclusive and empowering workplace, where diverse perspectives come together to innovate and advance our shared goals. Together, these efforts define our holistic approach to responsible business and our commitment to a healthier, more sustainable future for all.
In 2025, Biocon Biologics made its debut as an independent participant in the S&P Global Corporate Sustainability Assessment (CSA), with an impressive score of 53. Our S&P Global ESG Score saw a sharp increase by 20 points. S&P had assigned Biocon Biologics a score of 33 last year, without the Company participating in the CSA. Additionally, Biocon Biologics’ S&P Global CSA Score stands at 53, demonstrating our robust and responsible business operations. 
ESG is pivotal to what we do, how we work and what we deliver. By committing to integrity, setting clear objectives, identifying and assessing risks, having mitigation measures and implementing plans, and continually evaluating our effectiveness, we aim to drive sustainable long-term value and competitive advantage for us and our stakeholders, while seeking to fulfill our ESG commitments.
Our efforts in the pursuit of sustainable practices and responsible corporate citizenship have culminated in a comprehensive ESG roadmap, which encompasses a range of strategic actions and policy enhancements.
  • Environment

Increase 
Green Power

Boosting the use of renewable energy across our global operations

Reduce 
Freshwater Consumption
Lowering freshwater usage in all our facilities

Lower 
GHG Emissions

Continuing efforts to cut greenhouse gas (GHG) emissions, worldwide

Improve
Ecological Footprint
Integrating Life Cycle Assessment (LCA) from design to manufacturing, to reduce environmental impact

Reduce
Waste in Operations

Taking proactive steps to reduce plastic use, enhance recycling, and implement digital solutions to cut operational waste

Boost
Water Conservation

Enhancing water conservation through existing and improved recycling initiatives

Enhance
Recycling Processes

Advancing recycling and material reuse through authorized recyclers, to support a circular economy

Increase 
Biodiversity

Implementing eco-friendly practices, IUCN assessments, and active afforestation and gardening initiatives

  • Social

Increase
Access in LICs/LMICs

Expanding the availability of our biosimilars in low- and middle-income countries, which have the most urgent need 

Address
Global Healthcare Disparities
Making strategic medicine donations to non-profits in emerging markets

Ensure
Patient-Centricity

Offering comprehensive support through Patient Services and Assistance Programs

Advance
Capacity Building

Empowering healthcare professionals and patients with the knowledge and tools for effective disease management

Strengthen
Diversity, Equity, Inclusion & Belonging (DEIB)

Promoting initiatives that foster inclusion

Protect
Employee Health and Safety

Ensuring a safe work environment with proactive training, audits, and risk assessments for process safety and industrial hygiene

Foster
Employee Wellbeing and Development

Supporting employee engagement and growth through development programs that bridge skill-gaps and align with organizational values

Build
Community Services

Encouraging employees to contribute their talents to our initiatives in health, education and environmental sustainability

  • Governance

Key highlights of our Governance roadmap:

Audit and Reporting

  • Ensure audit and reporting processes meet the highest standards
  • Focus on audit readiness for all published non-financial data 
  • Commit to transparency, accuracy, and reliability

Business Ethics

  • Ensure audit and reporting processes meet the highest standards
  • Focus on audit readiness for all published non-financial data 
  • Commit to transparency, accuracy, and reliability

Supply Chain

  • Ensure ‘Business Partner Code of Conduct’ is understood and diligently implemented by all partners, such as suppliers, contract manufacturing organizations (CMOs), and other business associates
  • Foster a responsible supply chain
    Governance Documents & Policies
Governance Documents & Policies
Our ESG strategy is led from the top, with oversight and guidance provided by our Board of Directors through the Corporate Social Responsibility (CSR) & ESG Committee. This committee’s role is to monitor and enhance our ESG initiatives, embedding sustainable, responsible practices across the organization, ensuring we uphold a culture of transparency, accountability, and sustainable progress, reinforcing our commitment to responsible growth in healthcare.

Biocon Biologics’ CSR activities and ESG Roadmap are governed by a Board-constituted CSR & ESG Committee. The committee is chaired by Peter Piot, and its members include Kiran Mazumdar-Shaw, Shreehas Tambe, Nivruti Rai and Thomas Roberts. The primary responsibilities of committee members include:

  • Oversee our ESG program, strategy, initiatives, execution and disclosures
  • Identify areas of CSR activities, their implementation and the adoption of an Annual Action Plan
  • Ensure that CSR & ESG activities and plans are in line with the business, and mobilize resources and expertise for the initiatives
  • Make strategic grants to support worthwhile projects/programs, carrying out periodic reviews and reporting with respect to CSR and ESG activities
  • Ensure continuous compliance with statutory requirements, including formulation and amendment of the CSR Policy


We have an active ESG & CSR Board Committee, as well as a CSR ESG Steering Committee, to guide the core teams, work on our strategy, and oversee the execution of our initiatives.

Related Links

Environment

Biocon Biologics leads with purpose and responsibility. We drive innovation that not only transforms healthcare, but also safeguards the environment....
Read More

Social

Advancing social equity for patients, people, and communities is a core pillar of our responsibility. We are deeply committed to...
Read More

Connect with us

Subscribe

Our Parent Company

Quick Links

Our Parent Company
Facebook-f Youtube Linkedin-in

© 2025, Biocon Biologics Limited (a Subsidiary of Biocon Limited). All Rights Reserved

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree